In this study we showed that RXR-α has tumor suppressive function in hepatocytes and that reducing its expression increases β-catenin levels and signaling, whereas increasing RXR-α function by ligand activation lowered β-catenin levels and signaling. This evidence concerns the gene RXRA and neoplasm.